August J. Troendle

Director, Coherus BioSciences (United States).

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

  • Medpace MEDP5,119,911 shares3$3.2B at $622.70Sep 29, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

  • Sep 28, 2026Sold 2,410 shares at $620.07 of Medpace3
  • Sep 25, 2026Sold 154 shares at $620.60 of Medpace3
  • Sep 24, 2026Sold 27,833 shares at $621.33 of Medpace4
  • Sep 23, 2026Sold 16,083 shares at $628.64 of Medpace4
  • Sep 22, 2026Sold 49,018 shares at $628.11 of Medpace5
  • Sep 21, 2026Sold 21,883 shares at $623.29 of Medpace5
  • Sep 17, 2026Sold 10,880 shares at $620.40 of Medpace6
  • Sep 16, 2026Sold 8,770 shares at $621.29 of Medpace7
  • Sep 15, 2026Sold 15,971 shares at $620.84 of Medpace7
  • Aug 27, 2026Sold 650 shares at $620.27 of Medpace8
  • Aug 26, 2026Sold 4,000 shares at $620.03 of Medpace9
  • Aug 25, 2026Sold 673 shares at $620.38 of Medpace9
  • Aug 24, 2026Sold 1,983 shares at $620.23 of Medpace10
  • Aug 21, 2026Sold 13,995 shares at $624.45 of Medpace10
  • Aug 20, 2026Sold 27,174 shares at $618.79 of Medpace11
  • Aug 19, 2026Sold 15,609 shares at $606.47 of Medpace11
  • Aug 13, 2026Sold 458 shares at $600.39 of Medpace12
  • Aug 12, 2026Sold 11,366 shares at $601.53 of Medpace12
  • Aug 11, 2026Sold 17,610 shares at $605.11 of Medpace13
  • Aug 10, 2026Sold 5,534 shares at $601.53 of Medpace13
  • Jul 28, 2026Sold 3,510 shares at $600.01 of Medpace14
  • Jul 27, 2026Sold 3,728 shares at $600.85 of Medpace14
  • Dec 3, 2025Sold 668 shares at $590.69 of Medpace15
  • Dec 2, 2025Sold 5,698 shares at $590.47 of Medpace16
  • Dec 1, 2025Sold 23,178 shares at $593.25 of Medpace16